Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease

Anna Andreasson; Lars Agréus; Nikolaos Mastellos; Grzegorz Bliźniuk; Dorota Waśko-Czopnik; Agapi Angelaki; Eirini Theodosaki; Christos Lionis; Karin Hek; Robert Verheij; Ellen Wright; Stevo Durbaba; Jean Muris; Piotr Bródka; Stanislaw Saganowski; Jean-Francois Ethiér; Vasa Curcin; Brendan Delaney

doi:10.1080/07853890.2024.2354683

journal article Open Access May 16, 2024

Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease

Lars Agréus Nikolaos Mastellos Grzegorz Bliźniuk Dorota Waśko-Czopnik Agapi Angelaki Eirini Theodosaki Christos Lionis Karin Hek

Robert Verheij Ellen Wright Stevo Durbaba Jean Muris Piotr Bródka

Stanislaw Saganowski Jean-Francois Ethiér Vasa Curcin

Brendan Delaney

Annals of Medicine Vol. 56 No. 1 · Informa UK Limited

View at Publisher Save 10.1080/07853890.2024.2354683

Topics

No keywords indexed for this article. Browse by subject →

References

29

[1]

Symptoms in gastro-oesophageal reflux disease

A.G. Klauser, N.E. Schindlbeck, S.A. Müller-Lissner

The Lancet 10.1016/0140-6736(90)90287-f

[2]

10.1111/j.1572-0241.2006.00630.x

[3]

Yamasaki T, O’Neil J, Fass R. Update on functional heartburn. Gastroenterol Hepatol (N Y). 2017;13(12):725–734.

[4]

10.1080/00365520510011579

[5]

Gindea C, Birla R, Hoara P, et al. Barrett esophagus: history, definition and etiopathogeny. J Med Life. 2014;7(3):23–30.

[6]

10.1038/ajg.2009.706

[7]

10.1136/gut.2004.041517

[8]

10.1136/gut.2004.051821

[9]

An Increasing Incidence of Upper Gastrointestinal Disorders Over 23 Years: A Prospective Population-Based Study in Sweden

Anna Andreasson, Nicholas J. Talley, Marjorie M. Walker et al.

American Journal of Gastroenterology 10.14309/ajg.0000000000000972

[10]

Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community

Lars Agréus, Per M Hellström, Nicholas J Talley et al.

United European Gastroenterology Journal 10.1177/2050640615623369

[11]

10.1155/2018/6417526

[12]

10.1007/s12325-017-0532-9

[13]

10.5009/gnl16615

[14]

10.1111/j.1475-6773.2005.00404.x

[15]

Mortality prediction with a single general self-rated health question

Karen B. DeSalvo, Nicole Bloser, Kristi Reynolds et al.

Journal of General Internal Medicine 10.1111/j.1525-1497.2005.00291.x

[16]

10.2307/2955359

[17]

10.1093/fampra/cmv102

[18]

10.1016/j.ijmedinf.2017.06.006

[19]

10.1109/hicss.2015.383

[20]

Saganowski S, Misiaszek A, Brodka P, et al. TRANSFoRm eHealth solution for quality of life monitoring. AMIA Jt Summits Transl Sci Proc. 2016;2016:231–239.

[21]

10.1155/2016/1029368

[22]

Mastellos N, Andreasson A, Huckvale K, et al. A cluster randomised controlled trial evaluating the effectiveness of eHealth-supported patient recruitment in primary care research: the TRANSFoRm study protocol. Implement Sci. 2015;10(15).

[23]

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease

Michael J. Shaw, Nicholas J. Talley, Timothy J. Beebe et al.

American Journal of Gastroenterology 10.1111/j.1572-0241.2001.03451.x

[24]

Validating the SF-36 health survey questionnaire: new outcome measure for primary care.

J. E. Brazier, R. Harper, N. M. Jones et al.

BMJ 10.1136/bmj.305.6846.160

[25]

10.1016/s0140-6736(15)60175-1

[26]

10.1100/tsw.2011.2

[27]

10.1186/1477-7525-6-31

[28]

10.1136/gut.2006.100263

[29]

Boghossian TA, Rashid FJ, Thompson W, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3: CD011969.

Metrics

3

Citations

29

References

Details

Published: May 16, 2024
Vol/Issue: 56(1)
License: View

Authors

A

Anna Andreasson

Division of Psychobiology and Epidemiology, Department of Psychology, Stockholm University; Unit of Clinical Medicine, Department of Medicine Solna, Karolinska Institutet; School of Psychological Sciences, Macquarie University

L

Lars Agréus

Division for Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet

N

Nikolaos Mastellos

Department of Primary Care and Public Health, School of Public Health, Imperial College London

G

Grzegorz Bliźniuk

Faculty of Cybernetics, Military University of Technology

D

Dorota Waśko-Czopnik

Department of Gastroenterology and Hepatology Medical University Wroclaw ul. Borowska 213

A

Agapi Angelaki

Clinic of Social and Family Medicine, School of Medicine, University of Crete

E

Eirini Theodosaki

Clinic of Social and Family Medicine, School of Medicine, University of Crete

C

Christos Lionis

Clinic of Social and Family Medicine, School of Medicine, University of Crete

K

Karin Hek

Nivel, Netherlands Institute for Health Services Research

R

Robert Verheij

Nivel, Netherlands Institute for Health Services Research; Tilburg School of Social and Behavioral Sciences, Tilburg University; Health Care Institute Netherlands

E

Ellen Wright

School of Life Course & Population Sciences, Faculty of Life Sciences and Medicine, King’s College London

S

Stevo Durbaba

School of Life Course & Population Sciences, Faculty of Life Sciences and Medicine, King’s College London

J

Jean Muris

Department of Family Medicine, Maastricht University, Care and Public Health Research Institute

P

Piotr Bródka

Department of Artificial Intelligence, Wroclaw University of Science and Technology

S

Stanislaw Saganowski

Department of Artificial Intelligence, Wroclaw University of Science and Technology

J

Jean-Francois Ethiér

Groupe de recherche interdisciplinaire en informatique de la santé (GRIIS.ca), Université de Sherbrooke

V

Vasa Curcin

Department of Informatics, King’s College London

B

Brendan Delaney

Department of Department of Surgery and Cancer, Imperial College London

Cite This Article

Anna Andreasson, Lars Agréus, Nikolaos Mastellos, et al. (2024). Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease. Annals of Medicine, 56(1). https://doi.org/10.1080/07853890.2024.2354683

Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease

You May Also Like